Leonardo de Azevedo Boente

Suggest Changes
Learn More
BACKGROUND Treatment of metastatic colorectal adenocarcinoma (mCRC) has evolved, and survival is over 30 months in contemporary trials. Nevertheless, there is a paucity of effective regimes after the(More)
  • 1